Riskpilot← Back to searchSign inGet full accessCyclomedica Danmark ApS
APSActiveCVR 16582891Kirstinehøj 17, st.Wholesale of pharmaceutical and medical goods · NACE 4646Est. 19921 employees
Revenue 2025
DKK 560K
-27% vs 2024
EBITDA margin
29.3%
+1787% vs 2024
Equity ratio
34.3%
Financial strength
Net profit 2025
DKK 136K
+2442% vs 2024
| Revenue | DKK 560K | -27% |
| EBITDA | DKK 164K | +1787% |
| Net profit | DKK 136K | +2442% |
| Total assets | DKK 1,4M | +22% |
| Equity | DKK 479K | +40% |
| Employees | 1 | — |
Legal name
Cyclomedica Danmark ApS
CVR number
16582891
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1. november 1992
Share capital
DKK 500.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør i forening med et bestyrelsesmedlem, af et bestyrelsesmedlem eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at drive virksomhed med handel og industri
Address
Kirstinehøj 17, st.
Phone
+4532506610
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -2.474 | — | 3.870 | 4.209 | 3.421 | 2.672 | 1.669 | 1.740 | 1.273 | 671 | 622 | 831 | 766 | 560 |
| Staff expenses | -1.254 | -0 | -914 | -946 | -1.229 | -1.456 | -1.077 | -1.109 | -1.039 | -1.107 | -1.022 | -1.026 | -757 | -396 |
| EBITDA | -1.100 | 0 | 2.956 | 3.263 | 2.192 | 1.217 | 592 | 630 | 234 | -530 | -400 | -195 | 9 | 164 |
| Depreciation & amort. | -60 | -0 | -102 | -98 | -56 | -132 | -127 | -115 | -121 | -6 | -11 | -0 | -0 | -0 |
| EBIT | -1.160 | 0 | 2.854 | 3.165 | 2.136 | 1.084 | 465 | 516 | 113 | -536 | -410 | -195 | 9 | 164 |
| Net financials | -114 | 0 | -8 | 14 | 38 | 13 | 21 | 36 | 39 | 53 | 16 | 5 | -14 | -28 |
| Profit before tax | -1.047 | 0 | 2.846 | 3.179 | 2.174 | 1.097 | 486 | 552 | 152 | -483 | -394 | -191 | -6 | 136 |
| Tax | -271 | -0 | 716 | 748 | 484 | 244 | 112 | 127 | 37 | -104 | -0 | -2 | -0 | -0 |
| Net profit | -775 | 0 | 2.130 | 2.430 | 1.690 | 853 | 373 | 425 | 115 | -379 | -394 | -188 | -6 | 136 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 5.628 | 0 | 5.389 | 5.506 | 4.690 | 3.581 | 3.122 | 2.980 | 3.272 | 1.876 | 1.840 | 716 | 1.142 | 1.396 |
| Equity | 1.811 | 0 | 3.174 | 3.505 | 3.195 | 2.548 | 2.121 | 2.196 | 1.911 | 1.422 | 1.028 | 349 | 343 | 479 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 22 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | -3.806 | 0 | 2.176 | 1.962 | 1.449 | 984 | 955 | 746 | 1.312 | 452 | 731 | 368 | 799 | 917 |
| Total debt | -3.806 | 0 | 2.176 | 1.962 | 1.449 | 984 | 955 | 746 | 1.334 | 452 | 731 | 368 | 799 | 917 |
EBITDA margin
29.3%
This company
15.8%
Market median
+85% vs market
20122025
Equity ratio
34.3%
This company
38.2%
Market median
+10% vs market
20122025
Return on equity
28.4%
This company
18.4%
Market median
+54% vs market
20122025
Net profit margin
24.3%
This company
8.1%
Market median
+200% vs market
20122025
Asset turnover
0.40×
This company
1.12×
Market median
-64% vs market
20122025
Debt / equity
1.91×
This company
0.62×
Market median
-208% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
FV | Audit | 1992 | — | — |
SS Management | Management | 1992 | — | — |
JF Management | Management | 1992 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 1992 | — | — | |
| Board of Directors | 2023 | — | — | |
| Chairman | 1992 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 1992 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2023 | |
JAKOBSEN HOLDING ApS | Company | 100.0% | 100.0% | 1992 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Cyclomedica Danmark ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Frans Vestergren Thomsen | Audit | 0 companies |
| Steen Schierbeck | Management | 0 companies |
| Jan Fritz Rode Jakobsen | Management | 0 companies |
| Ulla Wulff Hansen | Board of Directors | 0 companies |
| James Steven Mc Brayer | Board of Directors | 0 companies |
| Hanna Bozena Jakobsen | Chairman | 0 companies |
| Mathew Farag | Board of Directors | 0 companies |
| Allan Sofus Ploug | Board of Directors | 0 companies |